These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2217915)

  • 21. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computer-aided rodent carcinogenicity prediction.
    Lagunin AA; Dearden JC; Filimonov DA; Poroikov VV
    Mutat Res; 2005 Oct; 586(2):138-46. PubMed ID: 16112600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative correlation of carcinogenic potency with four different classes of short-term test data.
    Travis CC; Wang LA; Waehner MJ
    Mutagenesis; 1991 Sep; 6(5):353-60. PubMed ID: 1795638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the carcinogenicity of chemicals in humans from rodent bioassay data.
    Goodman G; Wilson R
    Environ Health Perspect; 1991 Aug; 94():195-218. PubMed ID: 1954931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998.
    Gold LS; Manley NB; Slone TH; Rohrbach L; Garfinkel GB
    Toxicol Sci; 2005 Jun; 85(2):747-808. PubMed ID: 15800034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys.
    Gold LS; Manley NB; Slone TH; Ward JM
    Toxicol Pathol; 2001; 29(6):639-52. PubMed ID: 11794380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of cancer risk estimates based on a variety of risk assessment methodologies.
    Gold LS; Gaylor DW; Slone TH
    Regul Toxicol Pharmacol; 2003 Feb; 37(1):45-53. PubMed ID: 12662908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative and qualitative models for carcinogenicity prediction for non-congeneric chemicals using CP ANN method for regulatory uses.
    Fjodorova N; Vračko M; Tušar M; Jezierska A; Novič M; Kühne R; Schüürmann G
    Mol Divers; 2010 Aug; 14(3):581-94. PubMed ID: 19685274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the TD50 99 % CI for single dose rodent carcinogenicity studies.
    Thomas R; Oliveira AAF; Ponting DJ; Thresher A
    Toxicol Lett; 2023 Dec; 390():1-4. PubMed ID: 37923025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of TD
    Thresher A; Gosling JP; Williams R
    Toxicol Res (Camb); 2019 Sep; 8(5):696-703. PubMed ID: 31588346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the correlation coefficient between the TD50 and the MTD.
    Razzaghi M; Gaylor DW
    Risk Anal; 1996 Feb; 16(1):107-13. PubMed ID: 8868225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals I. Alternative toxicity measures as an estimator of carcinogenic potency.
    Venkatapathy R; Wang CY; Bruce RM; Moudgal C
    Toxicol Appl Pharmacol; 2009 Jan; 234(2):209-21. PubMed ID: 18977375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of in vitro cell transformation assays to predict the carcinogenic potential of chemicals.
    Isfort RJ; LeBoeuf RA
    Mutat Res; 1996 Sep; 365(1-3):161-73. PubMed ID: 8898996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of rodent carcinogenicity of aromatic amines: a quantitative structure-activity relationships model.
    Franke R; Gruska A; Giuliani A; Benigni R
    Carcinogenesis; 2001 Sep; 22(9):1561-71. PubMed ID: 11532881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A measure of tumorigenic potency incorporating dose-response shape.
    Meier KL; Bailer AJ; Portier CJ
    Biometrics; 1993 Sep; 49(3):917-26. PubMed ID: 8241378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The linearized multistage model and the future of quantitative risk assessment.
    Crump KS
    Hum Exp Toxicol; 1996 Oct; 15(10):787-98. PubMed ID: 8906427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extrapolation of carcinogenicity between species: qualitative and quantitative factors.
    Gold LS; Manley NB; Ames BN
    Risk Anal; 1992 Dec; 12(4):579-88. PubMed ID: 1480802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilisation of parametric methods to improve percentile-based estimates for the carcinogenic potency of nitrosamines.
    Thomas R; Thresher A; Ponting DJ
    Regul Toxicol Pharmacol; 2021 Apr; 121():104875. PubMed ID: 33556416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initiation-promotion model for assessment of carcinogenicity: medium-term liver bioassay in rats for rapid detection of carcinogenic agents.
    Imaida K; Fukushima S
    J Toxicol Sci; 1996 Dec; 21(5):483-7. PubMed ID: 9035059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.